Wharton Jelly derived mesenchymal stem cells (Medical University of Warsaw)
- Generic Name
- Wharton Jelly derived mesenchymal stem cells (Medical University of Warsaw)
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- University of Jordan
- Target Recruit Count
- 14
- Registration Number
- NCT06293950
- Locations
- 🇯🇴
Cell Therapy Center, Amman, Jordan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath